Melanie Manners FCIPD joins FutureMeds Executive Leadership Team and assumes the role of Group HR Director. Melanie will play a significant role in the European Site Network and DCT service provider’s future by driving its strategic objectives, fostering a positive culture through the Progress P.A.C.T., and ensuring that the organisation has the right talent to achieve its goals and drive value to FutureMeds' client-, partner-, and patient communities.
Melanie Manners, an accomplished global HR executive and non-executive director with over 25 years of experience across multi-site scale-ups, SMEs, and international corporate markets, joins FutureMeds.
Her appointment to the Executive Leadership Team signifies the European site network and DCT service provider’s commitment to fostering a people-first culture that will enable FutureMeds to increase its contribution to clinical research and drive more value to patients, clients, partners and the talented growing team.
“Melanie’s extensive background in organisational scale-up and transformation, particularly in the life sciences sector, aligns perfectly with FutureMeds’ growth ambitions and commitment to building a high-performing workplace. I am thrilled she joins our executive team to help us realise FutureMeds' vision.”
- Dr Radoslaw Janiak, CEO at FutureMeds
Working closely with the executive leadership team, Melanie will focus on advancing a people-first culture, ensuring that FutureMeds remains at the forefront of innovation and excellence in clinical research.
Most recently, Melanie served as VP of People at Eagle Genomics Ltd, where she was instrumental in scaling people operations and infrastructure on a global level. Her passion for purpose, sustainability, and impact has consistently driven her to create environments where talented individuals can thrive.
Based in the UK, Melanie is an honours graduate and a Chartered Fellow of the Institute of Personnel and Development (FCIPD). She is also a certified leadership coach and holds a Six Sigma Green Belt, further demonstrating her dedication to continuous improvement and excellence in people management.
Known for her entrepreneurial mindset, strategic thinking, and creative problem-solving abilities, Melanie excels in building highly capable teams, and her natural leadership skills make her well-suited to navigate unstructured and rapidly evolving environments.
“It is a privilege to be joining such an accomplished and purpose-driven executive leadership team at such a pivotal stage in FutureMeds’ evolution. The company is very well placed to transform outcomes for patients, partners, clients and colleagues, and I look forward to helping it accelerate as the employer of choice across the sector.”
- Melanie Manners, Group HR Director at FutureMeds
Melanie’s focus on leaving a lasting legacy and making the world a better place resonates deeply with FutureMeds values. With her guidance, FutureMeds is set to elevate internal culture, attract top talent and speed up sustainable growth, solidifying the European Site Network’s position at the forefront of clinical research and driving its mission to bring life-changing therapies to those in need.
About FutureMeds
Specialising in conducting clinical trials, FutureMeds is the 1st European Independent Dedicated DCT Site Network offering high levels of traditional and Decentralised Clinical Trial capabilities across the whole network and home nursing solutions in 18 European countries.
FutureMeds is driven by a purpose to connect a global healthcare community and help bring quicker access to life-changing medications and therapies to all those who need them worldwide.
FutureMeds’ Dedicated Research Site (DRS) teams serve as the company’s service foundation. DRS team’s capabilities help pharmaceutical companies and contract research organisations accelerate study timelines, streamline processes, lower costs, improve data quality and ultimately help speed up drug development and patient access to new treatments.
FutureMeds @home, the company’s Decentralised Clinical Trial solution, provides pharmaceutical companies, contract research organisations and other partners with powerful insights, tools, teams & support, enabling them to simplify patient access to trials and boost recruitment, engagement and retention.
Through its acquisitions, partnerships and a strategic focus on patient experience, FutureMeds brings opportunities to diverse European patient populations to participate in clinical research under the medical supervision of qualified physicians and health care professionals.
Follow us on LinkedIn
Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.
Comments